|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0017431,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0229671,
umls-concept:C0441889,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1996-3-7
|
|
pubmed:abstractText |
Since only a small proportion of patients with chronic hepatitis C benefit from interferon therapy, we assessed the viral factors such as HCV genotype and the level of viraemia for prediction of interferon response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-2977
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
265-71
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8569931-Adolescent,
pubmed-meshheading:8569931-Adult,
pubmed-meshheading:8569931-Aged,
pubmed-meshheading:8569931-Alanine Transaminase,
pubmed-meshheading:8569931-Antiviral Agents,
pubmed-meshheading:8569931-Chronic Disease,
pubmed-meshheading:8569931-Drug Monitoring,
pubmed-meshheading:8569931-Female,
pubmed-meshheading:8569931-Genotype,
pubmed-meshheading:8569931-Hepacivirus,
pubmed-meshheading:8569931-Hepatitis C,
pubmed-meshheading:8569931-Humans,
pubmed-meshheading:8569931-Interferon-alpha,
pubmed-meshheading:8569931-Male,
pubmed-meshheading:8569931-Middle Aged,
pubmed-meshheading:8569931-RNA, Viral,
pubmed-meshheading:8569931-Recombinant Proteins,
pubmed-meshheading:8569931-Serotyping
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Genotype, serum level of HCV-RNA and response to interferon-alpha treatment in patients with chronic hepatitis C.
|
|
pubmed:affiliation |
Department of Liver and Pancreatic Disease, University Hospital Gasthuisberg, University of Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
